Bryan J. Traynor

Bryan J. Traynor
Born1969 (age 56–57)
Dublin, Ireland
CitizenshipIrish-American
EducationUniversity College Dublin (MB, BCh, BAO; MD; PhD)
Harvard–MIT Program in Health Sciences and Technology (MMSc)
Known forCo-discovery of the C9orf72 hexanucleotide repeat expansion
AwardsBreakthrough Prize
Potamkin Prize
Sheila Essey Award
Scientific career
FieldsNeurology
Neurogenetics
Amyotrophic lateral sclerosis
Frontotemporal dementia
WorkplacesNational Institutes of Health (NIA)
Johns Hopkins University

Bryan J. Traynor is an Irish-American neurologist and neurogeneticist whose work focuses on the genetics of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). He is known for his contributions to the identification of the C9orf72 hexanucleotide repeat expansion as a major genetic cause of ALS and FTD. Traynor has conducted much of his work at the U.S. National Institutes of Health (NIH), where his research has examined genetic mechanisms underlying neurodegenerative disease and their potential clinical implications.

Traynor has received multiple awards recognizing his contributions to ALS and related dementia research, including the 2026 Breakthrough Prize in Life Sciences, the Potamkin Prize for Dementia Research, and the Sheila Essey Award.